Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sympathetic Vascular Transduction in Menopause
NCT06787066Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Missouri. Primary endpoint: Sympathetic transduction at 1 day. Started Jul 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06787066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787066.